{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-354738","form_type":"8-K","ticker":"NNDM","cik":"0001643303","company_name":"Nano Dimension Ltd.","filed_at":"2026-08-18T12:00:15+00:00","discovered_at":"2026-08-18T12:05:00.796972+00:00","generated_at":"2026-08-18T12:05:16.331031+00:00","sec_items":["5.02","7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Nano Dimension adds Nadav Kidron to board; Infinite Epigenetics exclusivity lapses without deal","bullets":["Nadav Kidron appointed to Nano Dimension board as Class II independent director, effective Aug 16, 2026; joins Audit and Compensation committees.","Kidron is CEO of Oramed Pharmaceuticals (ORMP) since 2006; also director at Lifeward (LFWD) and Alpha Tau (DRTS).","30-day exclusivity period under non-binding term sheet with Infinite Epigenetics expired July 15, 2026; no definitive agreement reached.","As of Aug 16, 2026, parties have not reached agreement on definitive terms; no further details disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-354738","json":"https://secwatch.observer/filing/0001193125-26-354738.json","markdown":"https://secwatch.observer/filing/0001193125-26-354738.md","text":"https://secwatch.observer/filing/0001193125-26-354738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1643303/000119312526354738/0001193125-26-354738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1643303/000119312526354738/nndm-20260816.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T12:05:16.331031+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd5df49964","claim":"Nadav Kidron was appointed as Class II director at Nano Dimension Ltd..","evidence_excerpt":"On August 16, 2026, the Board of Directors (the “Board”) of Nano Dimension Ltd. (the “Company”) appointed Nadav Kidron to the Board as a Class II director for the term expiring on the date of the annual meeting of the stockholders to be held in 2026 and until his successor is duly elected and qualified, or until his earlier resignation or removal, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1643303/000119312526354738/0001193125-26-354738-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}